Sort   by:  
 Page size 
UnknownCDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.
Not available
S-EPMC7252221 | biostudies-literature
UnknownThe Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials.
Not available
S-EPMC8657254 | biostudies-literature
UnknownA Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
Not available
S-EPMC6320304 | biostudies-literature
UnknownDarolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.
Not available
S-EPMC11552649 | biostudies-literature
UnknownDarolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Not available
S-EPMC9844551 | biostudies-literature
UnknownAn atlas of substrate specificities for the human serine/threonine kinome.
Not available
S-EPMC9876800 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownStandards in semen examination: publishing reproducible and reliable data based on high-quality methodology.
Not available
S-EPMC9627864 | biostudies-literature
UnknownWhat Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Not available
S-EPMC8849852 | biostudies-literature
UnknownManagement of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Not available
S-EPMC7614721 | biostudies-literature
Sort   by:  
 Page size